[YTL] QoQ TTM Result on 30-Jun-2024 [#4]

Announcement Date
21-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2024
Quarter
30-Jun-2024 [#4]
Profit Trend
QoQ- 2.56%
YoY- 108.2%
View:
Show?
TTM Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 30,781,896 30,529,002 31,356,420 31,478,047 30,540,533 29,508,152 26,484,413 10.51%
PBT 4,588,409 4,903,497 4,930,455 4,666,977 3,677,894 2,667,597 1,480,099 112.17%
Tax -922,225 -947,185 -1,056,289 -965,719 -809,839 -616,064 -396,682 75.22%
NP 3,666,184 3,956,312 3,874,166 3,701,258 2,868,055 2,051,533 1,083,417 124.89%
-
NP to SH 1,953,642 2,141,655 2,088,160 2,006,072 1,513,765 1,028,660 556,348 130.50%
-
Tax Rate 20.10% 19.32% 21.42% 20.69% 22.02% 23.09% 26.80% -
Total Cost 27,115,712 26,572,690 27,482,254 27,776,789 27,672,478 27,456,619 25,400,996 4.43%
-
Net Worth 15,529,218 16,270,699 16,009,513 15,240,357 15,020,797 14,253,311 13,156 10926.08%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 494,717 494,717 438,563 438,563 438,563 438,563 328,922 31.17%
Div Payout % 25.32% 23.10% 21.00% 21.86% 28.97% 42.63% 59.12% -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 15,529,218 16,270,699 16,009,513 15,240,357 15,020,797 14,253,311 13,156 10926.08%
NOSH 11,013,630 11,063,076 11,025,062 11,023,062 11,022,762 11,022,762 11,022,762 -0.05%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 11.91% 12.96% 12.36% 11.76% 9.39% 6.95% 4.09% -
ROE 12.58% 13.16% 13.04% 13.16% 10.08% 7.22% 4,228.56% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 279.49 277.70 285.96 287.10 278.55 269.13 241,556.05 -98.88%
EPS 17.74 19.48 19.04 18.30 13.81 9.38 5,074.28 -97.67%
DPS 4.50 4.50 4.00 4.00 4.00 4.00 3,000.00 -98.67%
NAPS 1.41 1.48 1.46 1.39 1.37 1.30 1.20 11.31%
Adjusted Per Share Value based on latest NOSH - 11,063,076
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 277.33 275.05 282.51 283.60 275.16 265.86 238.61 10.51%
EPS 17.60 19.30 18.81 18.07 13.64 9.27 5.01 130.56%
DPS 4.46 4.46 3.95 3.95 3.95 3.95 2.96 31.33%
NAPS 1.3991 1.4659 1.4424 1.3731 1.3533 1.2842 0.0012 10836.01%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 2.51 3.45 2.63 1.89 1.52 1.04 0.615 -
P/RPS 0.90 1.24 0.92 0.66 0.55 0.39 0.00 -
P/EPS 14.15 17.71 13.81 10.33 11.01 11.08 0.01 12338.41%
EY 7.07 5.65 7.24 9.68 9.08 9.02 8,250.86 -99.08%
DY 1.79 1.30 1.52 2.12 2.63 3.85 4,878.05 -99.48%
P/NAPS 1.78 2.33 1.80 1.36 1.11 0.80 0.51 129.56%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 26/11/24 21/08/24 23/05/24 22/02/24 23/11/23 24/08/23 25/05/23 -
Price 1.95 3.06 3.88 2.15 1.50 1.36 0.78 -
P/RPS 0.70 1.10 1.36 0.75 0.54 0.51 0.00 -
P/EPS 10.99 15.71 20.37 11.75 10.86 14.50 0.02 6532.14%
EY 9.10 6.37 4.91 8.51 9.20 6.90 6,505.48 -98.73%
DY 2.31 1.47 1.03 1.86 2.67 2.94 3,846.15 -99.27%
P/NAPS 1.38 2.07 2.66 1.55 1.09 1.05 0.65 64.96%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment